This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We have now added a new section called the "Assay History List" to the "At A Gla...